Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes

Infection and Immunity

Volumn 66, Issue 5, 1998, Pages 2033-2039

  Hutchison, Michael L ^a   Poxton, Ian R ^a   Govan, John R W ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOLYSIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; DEGRANULATION; INFECTION RISK; MOUSE; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL;

BURKHOLDERIA CEPACIA;

EID: 0031924967     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.5.2033-2039.1998     Document Type: Article

References (43)

1. Abe, M., and A. Nakazawa. 1994. Characterization of hemolytic and antifungal substance, cepalycin from Pseudomonas cepacia. Microbiol. Immunol. 38:1-9.
2. Burns, J. L. 1992. Characterization of invasion of epithelial cells by Pseudomonas cepacia. Pediatr. Pulmonol. Suppl. 8:201. (Abstract.)
3. Burns, J. L., M. Jonas, E. Y. Chi, D. K. Clark, A. Berger, and A. Griffith. 1996. Invasion of respiratory epithelial cells by Burkholderia cepacia. Infect. Immun. 64:4054-4059.
4. Butler, S. L., J. W. Nelson, and J. R. W. Govan. 1992. Cell surface characteristics of Pseudornonas cepacia isolates from patients with cystic fibrosis, abstr. TP8, p. 149. In Abstracts of the Eleventh International Cystic Fibrosis Congress.
5. Debentzmann, S., P. Roger, and E. Puchelle. 1996. Pseudomonas aeruginosa adherence to remodeling respiratory epithelium. Eur. Respir. J. 9:2145-2150.
6. FitzSimmons, S. 1996. United Stales Cystic Fibrosis Foundation Database. Cystic Fibrosis Foundation, Bethesda, Md.
7. Gilligan, P. H. 1991. Microbiology of airway disease in patients with cystic fibrosis. Clin. Microbiol. Rev. 4:35-51.
8. Goldman, D. A. and J. D. Klinger. 1986. Pseudomonas cepacia: biology. mechanisms of virulence, epidemiology. J. Pediatr. 108:806-812.
9. Govan, J. R. W., J. Hughes, and P. Vandamme. 1996. Burkholderia cepacia: medical, taxonomic and ecological issues. J. Med. Microbiol. 45:395-407.
10. Govan, J. R. W. G., P. H. Brown, J. Maddison, C. J. Doherty, J. W. Nelson, M. Dodd, A. P. Greening, and A. K. Webb. 1993. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 342:15-19.
11. Govan, J, R. W., and V. Deretic. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60:539-574.
12. Harkins, W. D., and F. E. Brown. 1919. The determination of the surface tension (free surface energy) and the weight of falling drops: the surface tension of water and benzene hy the capillary height method. J. Am. Chem. Soc. 41:449-503.
13. Hutchison, M. L., and D. C. Gross. 1997. Lipopeptide phytotoxins produced by Pseudomonas syringae pv. syringae: comparison of the biosurfactant and ion channel-forming activities of syringopeptin and syringomycin. Mol. Plant-Microbe Interact. 10:347-354.
14. Hutchison, M. L., M. A. Tester, and D. C. Gross. 1995. Role of biosurfactant and ion channel-forming activities of syringomycin in transmembrane ion flux: a model for the mechanism of action in the plant-pathogen interaction. Mol. Plant-Microbe Interact. 8:610-620.
15. Hutchison, M. L., and K. Johnstone. 1993. Evidence for the involvement of the surface active properties of the extracellular toxin tolassin in the manifestation of brown blotch disease symptoms by Pseudomonas tolaasii on Agaricus bisporus. Physiol. Mol. Plant Pathol. 42:373-384.
16. Immundo, L., J. Barasch, A. Prince, and Q. Al-Awqati. 1995. Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface. Proc. Natl. Acad. Sci. USA 92:3019-3023.
17. Isles, A., I. Maclusky, M. Corey, R. Gold, C. Prober, P. Fleming, and H. Levison. 1984. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J. Pediatr. 104:206-210.
18. Jarvis, W. R., D. Olson, O. Tablan, and W. J. Martone. 1987. The epidemiology of nosocomial Pseudomonas cepacita infections: endemic infections. Eur. J. Epidemiol. 3:233-236.
19. Johnson, W. M., S. B. Tyler, and K. R. Rozee. 1994. Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J. Clin. Microbiol. 32:924-930.
20. Jonas, D., I. Walev, T. Berger, M. Liebtrau, M. Palmer, and S. Bhakdi. 1994. Novel path to apoptosis: small transmembrane pores created by staphylococcal alpha-toxin in T lymphocytes evoke internucleosomal DNA degradation. Infect. Immun. 62:1304-1312.
21. Khelef, N., A. Zychlinsky, and N. Guiso. 1993. Bordetella pertussis induces apoptosis in macrophages: role of adenylate cyclase-hemolysin. Infect. Immun. 61:4064-4071.
22. Mahenthiralingam, E., M. E. Campbell, D. A. Hendry, and D. P. Speert. 1996. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis - analysis by randomly amplified polymorphic DNA-fingerprinting. J. Clin. Microbiol. 12:2914-2920.
23. Malka, R.-G., M. Poiret, and G. N. Cohen. 1970. The aspartatc kinase of Pseudomonas putidu regulation of synthesis and activity. Biochim. Biophys. Acta 206:17-30.
24. McKevitt, A. I., S. Bajaksouzian, J. D. Klinger, and D. E. Woods. 1989. Purification and characterization of an extracellular protease from Pseudomonas cepacia. Infect. Immun. 57:771-778.
25. Nakazawa, T., Y. Yamada, and M. Ishibashi. 1987. Characterisation of hemolysin in extracellular products of Pseudomonas cepacia. J. Clin. Microbiol. 25:195-198.
26. Nelson, J. W., S. L. Butler, D. Krieg, and J. R. W. Govan. 1984. Virulence factors of Burkholderia cepacia. FEMS Immunol. Med. Microbiol. 8:89-98
27. Palfreyman, R. W., M. L. Watson, C. Eden, and A. W. Smith. 1997. Induction of biologically active interleukin-8 from lung epithelial cells by Burkholderia (Pseudomonas) cepacia products. Infect. Immun. 65:617-622.
28. Pitt, T. L., M. E. Kaufmann, P. S. Patel, L. C. A. Benge, S. Gaskin, and D. M. Livermore. 1996. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J. Med. Microbiol. 44: 203-210.
29. Quinton, P. M., and M. M. Reddy. 1992. Control of CFTR chloride conductance by ATP levels through non-hydrolytic binding. Nature 360:79-81.
30. Revets, H., P. Vandamme, A. Van Zeeboeck, K. De Boeck, M. J. Struelens, J. Verhagen, J. P. Ursi, G. Verschraegen, H. Franckx, A. Malfroot, I. Dab, and S. Lauwers. 1996. Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium. Acta Clin. Belg. 51:222-230.
31. Riordan, J. R., J. M. Rommens, B. Kerem, N. Alon, R. Rozmahel, Z. Grzeiczak, J. Zielenski, S. Lok, N. Plavsic, J.-L. Chou, M. L. Drumm, M. C. Iannuzzi, F. S. Collins, and L. C. Tsui. 1989. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1059-1065.
32. Rosenberg, E. 1986. Microbial surfactants. Crit. Rev. Biotechnol. 3:109-132.
33. Sabitini, D. D., K., Benseh, and R. J. Barrnett. 1962. New means of fixation for electron microscopy and histochemistry. Anat. Rec. 142:274-279.
34. Shaw, D., I. R., Poxton, and J. R. W. Govan. 1995. Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide. FEMS Immunol. Med. Microbiol. 11:99-106.
35. Sheppard, J. D., and C. N. Mulligan. 1987. The production of surfactin by Bacillus subtilis grown on peat hydrolysate. Appl. Microhiol. Biotechnol. 27:110-116.
36. Simmonds, E. J., S. P. Conway, A. T. M. Ghoneim, H. Ross, and J. M. Littlewood. 1990. Pseudomonas cepacia: a new pathogen in patients with cystic fibrosis referred to a large centre in the United Kingdom. Arch. Dis. Child. 65:874-877.
37. Smith, J. J., S. M. Travis, E. P. Greenberg, and M. J. Welsh. 1996. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85:229-236.
38. + Pseudomonas (Burkholderia) cepacia causing CF center epidemics in North America and Britain. Nat. Med. 1:661-666.
39. Sylvester, F. A., U. S. Sajjan, and J. F. Forstner. 1996. Burkholderia (Basonym Pseudomonas) cepacia binding to lipid receptors. Infect. Immun. 64:1420-1425.
40. Thomassen, M. J., C. A. Demko, J. D. Klinger, and R. C. Stern. 1985. Pseudomonas cepacia colonization among patients with cystic fibrosis: a new opportunist. Am. Rev. Respir. Dis. 131:791-796.
41. Vandamme, P., B. Holmes, M. Vancanneyt, T. Coenye, B. Huste, R. Coopman, H. Revets, S. Lauwers, M. Gillis, K. Kersters, and J. R. W. Govan. 1997. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients; proposal of Burkholderia multivorans sp. nov. Int. J. Syst. Bacteriol. 47:1188-1200.
42. Vasil, M. L., D. P. Krieg, J. S. Kuhns, J. W. Ogle, V. D. Shortbridge, R. M. Ostroff, and A. I. Vasil. 1990. Molecular analysis of hemolytic and phospholipase C activities of Pseudomonas cepacia. Infect. Immun. 58:4020-4029.
43. Wilkinson, S. G., and T. L. Pitt. 1995. Burkholderia (Pseudomonas) cepacia: pathogenicity and resistance. Rev. Med. Microbiol. 6:10-17.